High Tower Advisors, LLC Precigen, Inc. Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 192,144 shares of PGEN stock, worth $144,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,144

Previous 66,999 186.79%

Holding current value

$144,108

Previous $105,000 73.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.91 - $1.88 $113,881 - $235,272	125,145 Added 186.79%	192,144 $182,000
Q2 2024 Aug 13, 2024	SELL	$1.27 - $1.75 $2,668 - $3,676	-2,101 Reduced 3.04%	66,999 $105,000
Q1 2024 May 06, 2024	SELL	$1.21 - $1.75 $20,271 - $29,317	-16,753 Reduced 19.51%	69,100 $100,000
Q4 2023 Feb 12, 2024	BUY	$0.89 - $1.41 $10,989 - $17,410	12,348 Added 16.8%	85,853 $115,000
Q3 2023 Nov 08, 2023	SELL	$1.08 - $1.85 $3,623 - $6,206	-3,355 Reduced 4.37%	73,505 $104,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $1,660 - $2,422	-1,730 Reduced 2.2%	76,860 $88,000
Q1 2023 May 11, 2023	BUY	$0.88 - $2.19 $801 - $1,995	911 Added 1.17%	78,590 $83,000
Q4 2022 Feb 08, 2023	SELL	$1.27 - $2.26 $76,034 - $135,306	-59,870 Reduced 43.53%	77,679 $118,000
Q3 2022 Nov 09, 2022	BUY	$1.41 - $2.79 $39,905 - $78,962	28,302 Added 25.91%	137,549 $285,000
Q2 2022 Aug 10, 2022	BUY	$1.15 - $2.53 $45,136 - $99,299	39,249 Added 56.07%	109,247 $142,000
Q1 2022 May 12, 2022	BUY	$1.91 - $3.98 $1,146 - $2,388	600 Added 0.86%	69,998 $146,000
Q4 2021 Feb 10, 2022	BUY	$3.53 - $5.5 $34,770 - $54,175	9,850 Added 16.54%	69,398 $256,000
Q3 2021 Nov 12, 2021	SELL	$4.99 - $6.55 $553 - $727	-111 Reduced 0.19%	59,548 $297,000
Q2 2021 Aug 06, 2021	SELL	$6.24 - $8.22 $17,846 - $23,509	-2,860 Reduced 4.57%	59,659 $386,000
Q1 2021 May 10, 2021	BUY	$6.74 - $10.95 $66,052 - $107,310	9,800 Added 18.59%	62,519 $430,000
Q4 2020 Feb 10, 2021	SELL	$3.75 - $10.56 $22,500 - $63,360	-6,000 Reduced 10.22%	52,719 $537,000
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $1,736 - $3,075	496 Added 0.85%	58,719 $206,000
Q2 2020 Aug 10, 2020	BUY	$2.16 - $5.46 $2,160 - $5,460	1,000 Added 1.75%	58,223 $290,000
Q1 2020 May 21, 2020	BUY	$1.46 - $7.19 $83,545 - $411,433	57,223 New	57,223 $191,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Precigen, Inc. Transaction History